This study endeavors to shed light on the utility of TNF-α and MCP-4 as potential biomarkers for MDD, advancing our understanding of the complex interplay between immune dysregulation and depressive disorders and offering promising insights into improved diagnostic and therapeutic approaches. This evidence concerns the gene CCL13 and major depressive disorder.